Ha, G., Kwong, K., Tanaka, B., Nishimura, Y. and Chong, C. 2023. Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease? iMCD after HHV-8-associated MCD. European Journal of Case Reports in Internal Medicine. 10, 7 (Jun. 2023). DOI:https://doi.org/10.12890/2023_003904.